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Abstract
T-cells and T-cell-derived cytokines are crucial mediators of protection against Mycobacterium tuberculosis infection, but these factors are
insufﬁcient as biomarkers for disease susceptibility. In order to deﬁne T-cell molecules involved in tuberculosis (TB), we compared gene
expression proﬁles of T-cells from patients with active TB, healthy donors with latent M. tuberculosis infection (LTBIs) and non-infected
healthy donors (NIDs) by microarray analysis. Pathway-focused analyses identiﬁed a prevalent subset of candidate genes involved in the
Janus kinase (JAK)–signal transducer and activator of transcription signalling pathway, including those encoding suppressor of cytokine
signalling (SOCS) molecules, in the subset of protection-associated genes. Differential expression was veriﬁed by quantitative PCR analy-
sis for the cytokine-inducible SH2-containing protein (CISH), SOCS3, JAK3, interleukin-2 receptor a-chain (IL2RA), and the proto-onco-
gene serine/threonine protein kinase (PIM1). Classiﬁcation analyses revealed that this set of molecules was able to discriminate
efﬁciently between T-cells from TB patients and those from LTBIs, and, notably, to achieve optimal discrimination between LTBIs and
NIDs. Further characterization by quantitative PCR revealed highly variable candidate gene expression in CD4+ and CD8+ T-cells
from TB patients and only minor differences between CD4+ and CD8+ T-cell subpopulations. These results point to a role of cytokine
receptor signalling regulation in T-cells in susceptibility to TB.
Keywords: Latent Mycobacterium tuberculosis infection, suppressor of cytokine signalling, T-cell subpopulations, T-cells, tuberculosis
Original Submission: 12 May 2010; Accepted: 8 July 2010
Editor: M. Drancourt
Article published online: 29 July 2010
Clin Microbiol Infect 2011; 17: 1323–1331
10.1111/j.1469-0691.2010.03326.x
Corresponding authors: M. Jacobsen, Department of Immunology,
Bernhard-Nocht-Institute for Tropical Medicine, Bernhard-Nocht-Str.
74, 20359 Hamburg, Germany
E-mail: Jacobsen@bni-hamburg.de
and
S. H. E. Kaufmann, Department of Immunology, Max Planck Institute
for Infection Biology, Charite´platz 1, 10117 Berlin, Germany
E-mail: kaufmann@mpiib-berlin.mpg.de
Introduction
Tuberculosis (TB) remains a major cause of morbidity and
mortality in humans worldwide, although only a minority of
individuals infected with Mycobacterium tuberculosis develop
active TB disease [1]. It is generally accepted that a func-
tional T-cell response is crucial for protection against
M. tuberculosis, but the precise underlying mechanisms remain
elusive [2].
Interferon-c and tumour necrosis factor-a are marker
cytokines of T-helper type 1 cell responses, which form the
basis of protective immunity against TB. Interferon-c acti-
vates macrophages, and enables them to overcome M. tuber-
culosis-induced arrest of phagosome maturation and major
histocompatibility complex class II-restricted antigen presen-
tation [3].
The role of CD8+ T-cells in the immune response against
TB remains controversial. There is evidence that CD8+
T-cells participate in the control of M. tuberculosis infection
by expression of effector cytokines [4,5], as well as lysis of
infected macrophages combined with killing of M. tuberculosis
[6,7]. Yet, analyses of CD8+ T-cell repertoires in children
with TB have identiﬁed clonal expansion of CD8+ terminally
differentiated effector T-cells in severe forms of disease [8].
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Hence, CD8+ T-cells may serve targets of immune evasion
by M. tuberculosis.
T-cell responses to pathogens are regulated by T-cell
receptor afﬁnity/avidity, co-receptor engagement (e.g. CD28
and cytotoxic T-lymphocyte antigen-4), and cytokine recep-
tor signalling. Common cytokine c-chain receptors, such as
the interleukin (IL)-2 receptor, signal via the Janus kinase
(JAK)–signal transducer and activator of transcription
(STAT) signalling pathway [9], and the regulation of these
processes is mediated by several molecules, including mem-
bers of the suppressor of cytokine signalling (SOCS) family
[10] and serine/threonine protein kinases (PIMs) [11,12].
The SOCS family comprises eight molecules, and at least
four of these, namely CISH, SOCS1, SOCS2, and SOCS3,
are expressed in T-cells [10]. SOCS molecules act as feed-
back inhibitors induced by different stimuli, including cyto-
kines and Toll-like receptor ligands (reviewed in [13]).
SOCS-mediated regulation of T-cell functions leads to
immune polarization. In animal models, it has been shown,
for example, that SOCS3 overexpression inhibits differentia-
tion of T-helper type 17 (Th17) cells [14] and regulatory T-
cells [15]. In CD8+ T-cells, SOCS3 is involved in the control
of IL-6-induced and IL-27-induced proliferation [16]. Like
SOCS molecules, PIMs are induced by cytokine signalling via
the JAK–STAT signalling pathway. PIM1 participates in cell
survival, proliferation, and carcinogenesis [17]. It has antia-
poptotic functions and interacts with several other proteins,
including members of the SOCS family [18]. Therefore,
SOCS and PIM molecules may be important targets of
immune polarization induced by pathogens.
The present study determined the global gene expression
proﬁle of T-cells from TB patients, patients with latent
M. tuberculosis infection (LTBIs), and non-infected healthy
donors (NIDs), to determine novel candidates involved in
protective immunity against TB.
Materials and Methods
TB patients, LTBIs, and NIDs
Forty-two TB patients, 42 LTBIs and ten NIDs were
recruited at Tygerberg hospital, and six TB patients were
recruited at the University Hospital Eppendorf, Hamburg.
Diagnosis was based on chest radiography, tuberculin skin
test, Quantiferon test, and laboratory conﬁrmation of
M. tuberculosis culture. All TB patients were human immuno-
deﬁciency virus-negative and had been included prior to che-
motherapy. Features of patients and healthy donors are
summarized in Table 1. All donors gave informed consent.
This study was approved by local ethics committees in
Stellenbosch (South Africa) (N05/11/187), Berlin (Germany)
(EA 1/176/07), and Hamburg (WF-07/09) (Germany).
Isolation of T-cells from peripheral blood
We isolated peripheral blood mononuclear cells from 40 mL of
heparinized blood by Ficoll density centrifugation (Biochrom,
Berlin, Germany), following the manufacturer’s instructions.
We separated T-cell populations by magnetic cell sorting with
magnetically labeled aCD3, aCD4 or aCD8 antibodies (Miltenyi
Biotech, Bergisch Gladbach, Germany) and enrichment
columns (MS columns; Miltenyi Biotech), following the manufac-
turer’s instructions. To avoid any inﬂuence on T-cell RNA
expression, all steps were performed on ice. The purity of
CD3+ T-cells was 98.9% ± 0.9% for TB patients, 98.0% ± 2.4%
for LTBIs, and 99.2% ± 0.6% for NIDs. Isolation of CD4+ and
CD8+ T-cell subpopulations was performed by ﬂuorescence-
activated cell sorting (FACS), with the following antibodies:
CD4-APC-Cy7, CD8-PerCP-Cy5.5, CD45RO-Pe-Cy7, and
CD62L-APC (all BD Biosciences, Franklin Lakes, NJ, USA).
Staining procedures have been described previously [19].
A FACS-Aria was used, and the purity was found to be >95%.
Preparation of RNA from T-cells and T-cell subpopulations
After isolation, T-cells were immediately mixed with TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) and frozen at
)80C until RNA was extracted according to the manufac-
turer’s instructions. RNA content, purity and integrity were
determined with an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, Forster City, CA, USA).
Microarray procedures: experimental design
Total RNA was labelled with a Fluorescent Linear Ampliﬁca-
tion Kit (Agilent Technologies), following the manufacturer’s
instructions. After photometric quantiﬁcation of cRNA and
determination of labelling efﬁciency, 2-lg portions of samples
were fragmented and hybridized for 20 h on whole genome
oligonucleotide microarrays (Agilent Technologies). Each
T-cell RNA sample from TB patients was co-hybridized with
T-cell RNA from a gender-matched and age-matched LTBI
to avoid age-dependent or gender-dependent biases. Because
of the lower number of NIDs recruited, each NID T-cell
TABLE 1. Donor characteristics
Feature TB patients LTBIs NIDs
Total no. 42 42 10
Gender
Male 19 19 4
Female 23 23 6
Age (years), mean (SD) 29.0 (10.4) 28.2 (9.3) 25.0 (11.7)
TB, tuberculosis; LTBI, healthy donors with latent Mycobacterium tuberculosis
infection; NID, non-infected healthy donors; SD, standard deviation.
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RNA was compared with T-cell RNA of an RNA pool from
ﬁve age-matched and gender-matched TB patients and LTBIs,
respectively. Relative comparison of two samples on this
type of microarray is based on labelling with different dyes
(i.e. Cy3 and Cy5) for co-hybridized samples. To avoid a
possible dye-speciﬁc bias, an independent swap design [20]
was introduced for the hybridizations.
Microarrays were processed according to the manufac-
turer’s instructions, and scanned at 5-lm resolution with an
Agilent scanner. Image analysis was performed with feature
extraction software (Feature Extractor Version 6.1.1; Agilent
Technologies), using default settings and global background
normalization. Candidate gene lists were calculated as speci-
ﬁed below.
Real-time quantitative PCR (qPCR) analysis
RNA was reverse-transcribed to cDNA as described previ-
ously [21]. SYBR Green (Applied Biosystems, Foster City, CA,
USA) uptake in double-stranded DNA was measured with an
ABI PRISM 7900 thermocycler (Applied Biosystems), accord-
ing to the manufacturer’s instructions. We designed primer
pairs with the ABI PRISM primer express Version 2.0.0 soft-
ware (Applied Biosystems) for real-time qPCR analysis. The
primer pairs for candidate gene veriﬁcation are listed in
TABLE 2. Candidate gene primer
sequences
Candidate gene Forward primer (5¢ to 3¢) Reverse primer (5¢ to 3¢)
CISH TGTGCATAGCCAAGACCTTCTC CGTAATGGAACCCCAATACCA
SOCS2 TGTTCACCTTTATCTGACCAAACC GCCTACAGAGATGCTGCAGAGA
SOCS3 GACCAGCGCCACTTCTTCAC CTGGATGCGCAGGTTCTTG
JAK3 GCCTGGAGTGGCATGAGAA CCCCGGTAAATCTTGGTGAA
STAT3 CCCCATACCTGAAGACCAAGTTTA CTTCACCATTATTTCCAAACTGCAT
IL2RA CCAGCTCAGTCCCATCAGAGA TTCAACGGCGAAATTGCTATT
PIM1 CGAGCATGACGAAGAGATCAT TCGAAGGTTGGCCTATCTGA
MYC CACTTTGCACTGGAACTTACAACA CCCGCGTCGGGAGAGT
GAPDH ATGGAAATCCCATCACCATCTT CGCCCCACTTGATTTTGG
CISH, cytokine-inducible SH2-containing protein; SOCS, suppressor of cytokine signalling; JAK, Janus kinase; STAT,
signal transducer and activator of transcription; PIM1, serine/threonine protein kinase; IL2RA, interleukin-2 receptor
a-chain; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
(a)
FIG. 1. Global transcriptome compari-
son of tuberculosis (TB) patients,
healthy donors with latent Mycobacte-
rium tuberculosis infection (LTBIs) and
non-infected healthy donors (NID). Gra-
phic illustration of differential gene
expression measured by microarray
analysis for: (a) TB patients vs. LTBIs,
(b) LTBIs vs. NIDs, and (c) TB patients
vs. NIDs. Heat map presentations indi-
cate increased expression of genes for
the ﬁrst study group (blue) and the sec-
ond study group (yellow). Gene identiﬁ-
ers are shown on the right side of each
plot.
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Table 2. Glyceraldehyde-3-phosphate dehydrogenase was used
as an internal control for all analyses. Because of limitations in
the sample volumes, not all individuals could be included for
each candidate gene. Respective numbers are indicated in the
ﬁgure legends. The Mann–Whitney U-test or Student’s t-test
was used to determine signiﬁcant differences in qPCR data for
candidate genes between study groups. The appropriate test
was selected on the basis of Kolmogorov–Smirnov normality
testing (Sigmaplot 10.0.1; Systat, Chicago, IL, USA).
Candidates for differential gene expression for pairwise
comparisons of LTBIs, NIDs and TB patients: statistical
analysis
Raw microarray data were processed with the function
read.maimages of the Bioconductor [22] R package limma
[23]. Low-quality spots were detected by the use of eight qual-
ity features described in the reference guide of the Agilent
Feature Extraction Software (Agilent Technologies, 2008).
Then, raw intensities of the spots not ﬂagged out were
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background-corrected with the norm-exp method [24] of the
R package limma. Background-corrected values were Lowess-
normalized to obtain as unbiased red/green ratios as possible.
For global comparability, the data of all arrays were quantile-
normalized [25]. Furthermore, features with mean log intensi-
ties <7 were also ﬂagged out, because, for these low-intensity
spots, random noise in the data would lead to spurious signals.
To statistically test for differential expression in the three
pairwise comparisons of LTBs, NIDs and TB patients, we
applied a combination of t-tests with subsequent false discov-
ery rate correction, based on the approach of Efron and
Tibshirani [26], and log fold/change cut-offs as follows: TB vs.
NID, q < 0.05, abs(log fold/change) >0.6; TB vs. LTBI,
q < 0.05, abs(log fold/change) >0.5; and NID vs. LTBI,
q < 0.05, abs(log fold/change) >0.25.
Classiﬁcation of TB patients, LTBIs and NIDs with the use
of six candidate biomarkers
Six selected features (PIM1, SOCS3, CISH, JAK3, MYC, and
IL2RA) were used in a linear discriminant analysis approach
(as implemented in R function lda (package MASS)), to build
a classiﬁer discriminating between TB patients and LTBIs, as
well as between LTBIs and NIDs. For this purpose, the nor-
malized two-colour microarray data were reparametrized: if
we assign A = mean(log(TB),log(LTBI)) and M = log(fold
change), we are able to isolate both log intensities (as
proposed in [27]) to yield log(TB) = A + 0.5*M and
log(LTBI) = A ) 0.5*M. Linear discriminant analysis for 42
cases of TB and 42 LTBIs was performed with the R package
lda [24]. To display classiﬁcations and certainty of prediction,
TABLE 3. TB protection-associated candidate genes
GeneSymbol p.raw p.BY meanM meanA
PIM1 0,0000000000000006 0,00000000001 0.99 13.16
THC2328806 0,0000000000001 0,000000001 0.82 7.32
THC2347909 0,0000000000004 0,000000002 )0.94 9.24
BM665043 0,000000000002 0,00000001 0.55 10.81
SOCS3 0,000000000002 0,00000001 1.16 9.54
PIM2 0,000000000003 0,00000001 0.56 11.20
TLR1 0,00000000003 0,0000001 0.56 8.47
TMEM49 0,0000000004 0,000001 0.69 8.65
NFKBIZ 0,0000000005 0,000001 0.80 10.88
MGC16044 0,00000001 0,00001 0.54 11.55
BCL3 0,0000001 0,0001 0.96 12.04
MGC29814 0,0000003 0,0001 0.62 13.88
N47124 0,0000003 0,0001 0.63 8.98
C6orf105 0,000001 0,0002 0.71 9.56
FCGBP 0,000001 0,0002 )0.71 9.59
HBB 0,000001 0,0004 1.69 9.54
GZMK 0,000002 0,001 )0.75 10.79
BATF 0,000004 0,001 0.58 11.36
HBD 0,000005 0,001 0.55 7.53
S100A8 0,00002 0,003 1.16 10.54
DACT1 0,00003 0,003 0.62 8.44
MNDA 0,00004 0,004 0.54 7.45
FLJ22662 0,0001 0,008 0.68 7.46
HDGFRP3 0,0001 0,008 0.54 7.87
IER5 0,0002 0,010 )0.54 12.10
CISH 0,0002 0,012 0.79 10.51
S100A9 0,0004 0,019 0.66 7.89
ENST00000322032 0,001 0,022 0.56 9.28
CCL5 0,001 0,023 )0.53 11.36
SGK 0,001 0,032 0.67 8.99
DUSP2 0,001 0,033 )0.58 10.02
TK1 0,001 0,039 0.50 9.07
SOCS3
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FIG. 2. Functional categorization and veriﬁcation of JAK–STAT path-
way-related candidate genes. (a) Depiction of the JAK–STAT path-
way of cytokine signal transduction and regulatory components
differentially expressed in transcriptome analysis. (b) Real-time PCR
analysis of candidate genes from the JAK–STAT signalling pathway.
Box plots indicate gene expression levels as PCR cycle differences
frpm glyceraldehyde-3-phosphate dehydrogenase (GAPD) (y-axis) of
cytokine-inducible SH2-containing protein (CISH), suppressor of
cytokine signalling (SOCS)2, SOCS3, Janus kinase (JAK)3, signal
transducer and activator of transcription (STAT)3, interleukin-2
receptor a-chain (IL2RA), serine/threonine protein kinase (PIM1) and
MYC for tuberculosis (TB) patients (dark grey), healthy donors with
latent Mycobacterium tuberculosis infection (LTBIs) (light grey), and
non-infected healthy donors (NIDs) (white), respectively. Because of
restrictions in donor material, only subgroups of donors have been
included in these analyses. Forty-one TB patients, 40 LTBIs and eight
NID have been included for SOCS3, SOCS2, CISH, JAK3, IL2RA,
and MYC. Seventeen TB patients, 16 LTBIs and eight NIDs have
been included for STAT-3. Twenty-one TB patients, 27 LTBIs and
four NIDs have been included for PIM1. Box plots and error bars
represent 5, 25, 50, 75 and 95 percentiles. Nominal two-sided p-val-
ues for the Mann–Whitney U-test are indicated as *** for p <0.001.
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in a cross-validation approach we calculated the differences
in absolute posterior classiﬁcation probabilities for each of
the 84 cases. In addition, coefﬁcients of the discriminant
functions were divided by mean values of the respective
features, resulting in estimates for feature importance.
Results
Protection-associated genes from transcriptome comparison
Our previous studies revealed marked inﬂuences of blood
cell heterogeneity on the analyses and interpretation of
microarray results from peripheral blood of TB patients and
LTBIs [28,29]. Consequently, we isolated T-cells from
peripheral blood prior to RNA analyses in the present study.
Global mRNA expression of T-cells from three study groups,
i.e. TB patients, LTBIs and NIDs from a TB high-incidence
country, was analysed (for donor details, see Table 1). We
compared gender-matched and age-matched individuals,
including 42 TB patients, 42 LTBIs, and ten NIDs (see
Materials and Methods for details). Differentially expressed
genes of three different comparisons, namely, TB patients vs.
LTBIs (A), TB patients vs. NIDs (B), and NIDs vs. LTBIs (C),
are graphically depicted in Fig. 1. We focused on the candi-
date gene set from comparison A (Fig. 1a), because differ-
ences in this comparison are assumed to at least partly
reﬂect latent M. tuberculosis infection protection. In order to
separate pathognomic markers from comparison A, we
excluded differentially regulated genes from comparison B.
This preselection resulted in a set of 33 T-cell molecules that
TB   LTBI
Prediction strength 
TB   LTBI
Prediction strength 
IL2RA JAK3 SOCS3 MYC PIM1 CISH
0.00
0.05
0.10
0.15
0.20
(c)
(b)(a)
IL2RA JAK3 SOCS3 MYC PIM1 CISH
0.0
0.2
0.4
0.6
0.8
1.0
1.2
(d)
FIG. 3. Classiﬁcation of candidate genes from the Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway by linear
discriminant analysis. (a, b) Results from the training step leave-one-out cross-validation are shown as horizontal bar charts. Each bar represents
an individual donor. (a) Healthy donors with latent Mycobacterium tuberculosis infection (LTBIs) are depicted in the upper part (light grey), and
tuberculosis (TB) patients are depicted in the lower part (dark grey). Negative bar values represent TB disease prediction, including prediction
validity as bar width. Positive values predict LTBIs. (b) LTBIs are depicted in the upper part (light grey), and non-infected healthy donors (NIDs)
are depicted in the lower part (dark grey). Negative bar values represent LTBI prediction, including prediction validity as bar width. Positive val-
ues predict NIDs. (c, d) Feature importance plots (y-axis, coefﬁcients of discriminant function normalized with mean signal intensities), indicating
the relative importance of each factor (x-axis) for classiﬁcation. CIS, cytokine-inducible SH2-containing protein; IL2RA, interleukin-2 receptor
a-chain; PIM1, serine/threonine protein kinase.
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are probably involved in protection against TB. The candi-
date list contained 33 differentially expressed genes
(q < 0.05, Table 3) after adjustment for multiple testing
according to Storey and Tibshirani [30], as well as application
of a cut-off of log fold change of M > 0.5 (see Material and
Methods for full details).
Veriﬁcation of candidate genes involved in the regulation of
cytokine signalling
Functional annotation of candidate genes with DAVID
(http://david.abcc.ncifcrf.gov/) identiﬁed enrichment of genes
involved in the JAK–STAT signalling pathway, including two
members of the SOCS family (i.e. CIS and SOCS3), and PIM1
(p 0.01). CIS, SOCS3 and PIM1 are invariably induced by
molecules of the JAK–STAT pathway, and CIS, SOCS3 and
PIM1 are inhibitory feedback regulators of this pathway
(schematically depicted in Fig. 2a). Additional molecules
involved in the JAK–STAT signalling pathway were identiﬁed
within the ﬁrst 134 genes of the ranking list, namely, STAT4
(rank 24), SOCS2 (rank 54), JAK3 (rank 134), and IL2RA
(rank 88). To verify differential expression, we performed
real-time PCR analysis. For CISH, SOCS3, JAK3, PIM1, IL2RA
and MYC, expression differences between TB patients and
LTBIs were veriﬁed (Fig. 2b). None of these candidates was
differentially expressed between TB patients and NIDs
(Fig. 2b). Notably, SOCS3 and MYC expression levels were
also lower in LTBIs than in NIDs (SOCS3, p <0.001; MYC,
p <0.05). These ﬁndings argue against higher expression of
SOCS3 and MYC in T-cells as a pathognomic marker during
active TB, and suggest decreased expression of SOCS3 and
MYC in T-cells from LTBIs.
Classiﬁcation using candidate genes associated with
protection against TB
PIM1, SOCS3, CISH, JAK3, MYC and IL2RA were used for a
discriminant analysis to build a classiﬁer signature discriminat-
ing between TB patients, LTBIs, and NIDs (see Material and
Methods for details) [24]. Classiﬁcation analyses for TB
patients and LTBIs revealed 89% (73/84) prediction accuracy
(Fig. 3a), and the relative feature importance score identiﬁed
IL2RA, JAK3 and SOCS3 as predominant contributors to
these results (Fig. 3c). Notably, the comparison between
LTBIs (RNA pool of ﬁve donors) and NIDs showed 100%
correct prediction for ten comparisons (Fig. 3b), and PIM1
and IL2RA were the most inﬂuential factors (Fig. 3d).
Candidate gene expression in CD4+ and CD8+ T-cells and
subpopulations
Different subsets of T-cells may differentially contribute to can-
didate gene expression, and these differences may confound
gene expression analyses [28,29]. Therefore, we determined
the expression of candidate genes from TB patients in CD4+
and CD8+ T-cells from six TB patients, but detected no signiﬁ-
10
1
0.1
(b)
(a)
CD4+
Tnaïve TCM TEM TEF
SOCS3
–5
0
5
10
JAK3 PIM1CISH
0.1
0.01
1
CD8+
Tnaïve TCM TEM TEF
FIG. 4. Expression of candidate genes in CD4+ and CD8+ T-cells
and subpopulations. (a) Box plots indicate gene expression differ-
ences as PCR cycle differences from glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (y-axis) of suppressor of cytokine signalling
(SOCS)3, Janus kinase (JAK)3, serine/threonine protein kinase (PIM1)
and CISH for CD4+ (coarse hatching) and CD8+ (medium hatching)
T-cells from six tuberculosis patients. Box plots represent 25, 50 and
75 percentiles. (b, c) SOCS3 expression in CD4+ (b) and CD8+ (c)
T-cell subpopulations is depicted. Bars indicate the relative expres-
sion of SOCS3 in comparison with GAPDH. A representative experi-
ment of three experiments is shown. Tnaive, naı¨ve T-cell; TCM, central
memory T-cell; TEM, effector memory T-cell; TEF, effector T-cell.
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cant differences between CD4+ and CD8+ T-cell subsets
(Fig. 4a). Very little is known about SOCS3 expression in
human T-cell subpopulations. Therefore, we isolated naı¨ve,
central memory, effector memory and effector CD4+ and
CD8+ subpopulations by FACS. Analyses revealed comparable
expression levels of SOCS3 in naı¨ve and memory T-cells, but
slightly lower expression in effector T-cells (Fig. 4b).
Our results emphasize a role of cytokine receptor signal-
ling and induction of inhibitory regulators in the T-cell
response against M. tuberculosis. Further experiments will
determine how these differences translate into functional
changes in the T-cell response during TB.
Discussion
Transcriptome analyses from TB patients and healthy con-
tacts indicate a role of JAK–STAT signalling and pathway reg-
ulation of T-cells by SOCS family members in TB.
There is increasing evidence that immune polarization may
affect disease susceptibility in TB [31–33], and the present
study suggests that regulation of cytokine signalling via the
JAK–STAT pathway may be a crucial step in this process.
One cytokine receptor candidate is the IL-2 receptor. IL2RA
(CD25) is expressed on activated T-cells and regulatory
T-cells. We detected increased expression of CD25 mRNA
in T-cells from TB patients. This may be explained by an
enforced activation state of circulating T-cells or increased
proportions of regulatory T-cells in TB patients; alternatively,
this may represent a backlash of T-cells in response to
increased inhibition by SOCS molecules, such as SOCS3.
Higher SOCS3 expression in whole blood from TB patients
and patients with recurrent TB as compared to LTBIs has
been described previously [34], and SOCS3 expression was
found to decrease under chemotherapy [34]. We detected
differential expression of SOCS3 between TB patients and
LTBIs, but not between TB patients and NIDs, and decreased
expression of SOCS3 in T-cells from LTBIs as compared with
NIDs. This encouraged us to speculate that the reduction of
SOCS3 expression improves the protective capacities of
T-cells against M. tuberculosis. SOCS3 overexpression in mice
leads to immune polarization, promoting generation of
T-helper type 2 cells [35] and suppression of Th17 responses
[14]. The role of Th17 cells in TB remains elusive, but a path-
ological role of IL-4 and the T-helper type 2 response has
been described (reviewed in [31]). Therefore, we assume that
regulation of SOCS3 in T-cells is an important immune-
polarizing process during M. tuberculosis infection. Further
longitudinal studies will determine the usefulness of SOCS3 as
a prognostic biomarker for the risk of TB in LTBIs.
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